Richard A. Fair - Aug 15, 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
President and CEO, Director
Signature
/s/ Richard A. Fair
Stock symbol
BLCM
Transactions as of
Aug 15, 2022
Transactions value $
$576,000
Form type
4
Date filed
8/16/2022, 05:04 PM
Previous filing
Aug 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $576K +400K $1.44 400K Aug 15, 2022 Common Stock 400K $1.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3rd) of the shares subject to the option will vest on the one-year anniversary on August 16, 2023, and the remaining shares will vest in twenty-four (24) equal monthly installments thereafter.